20 research outputs found
Preimaginal Stages of the Emerald Ash Borer, Agrilus planipennis Fairmaire (Coleoptera: Buprestidae): An Invasive Pest on Ash Trees (Fraxinus)
This study provides the most detailed description of the immature stages of Agrilus planipennis Fairmaire to date and illustrates suites of larval characters useful in distinguishing among Agrilus Curtis species and instars. Immature stages of eight species of Agrilus were examined and imaged using light and scanning electron microscopy. For A. planipennis all preimaginal stages (egg, instars I-IV, prepupa and pupa) were described. A combination of 14 character states were identified that serve to identify larvae of A. planipennis. Our results support the segregation of Agrilus larvae into two informal assemblages based on characters of the mouthparts, prothorax, and abdomen: the A. viridis and A. ater assemblages, with A. planipennis being more similar to the former. Additional evidence is provided in favor of excluding A. planipennis from the subgenus Uragrilus
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study
Peer reviewe
Aziatische essenprachtkever kan ramp veroorzaken
De essenprachtkever is nog niet aanwezig in Europa, maar kan zomaar als larve worden geïmporteerd in dood of levend essenhout. De kever is door uitgebreide vraat aan het cambium dodelijk voor essenbomen. PD en Alterra zijn beducht voor de komst van deze Aziaat
Aziatische boktor dreigend gevaar voor bomen
Ondanks importcontroles hebben Aziatische boktorren, Anoplophora glabripennis, zich in Europa, maar nog niet in Nederland, weten te vestigen. Voor hun levenscyclus benutten ze allerlei boomsoorten en vormen zo een bedreiging voor bomen in stad en landschap. De boktorren hebben de voorkeur voor esdoorn, populier, wilg en paardenkastanje. Voor tijdige signalering is de Plantenziektekundige Dienst aangewezen op oplettende groenbeheerders. Herkenning van de torren, schadebeeld en symptomen worden behandel
Anoplophora Chinensis & Anoplophora Glabripennis: new tools for predicting, detecting and fighting. How to save our forests and our urban green spaces
<p>Special issue on:</p><p><em>Anoplophora Chinensis & Anoplophora Glabripennis: new tools for predicting, detecting and fighting. </em><br /><em>How to save our forests and our urban green spaces </em></p><p>Milan, 9-11 May 2012</p><p> </p><p>A conference sponsored by the OECD’s co-operative research programme on biological resource management for sustainable agricultural systems</p
Import-inspections, surveys, detection and eradication of the longhorn beetles Anoplophora chinensis and A. glabripennis in The Netherlands.
A conference sponsored by the OECD’s co-operative research programme on biological resource management for sustainable agricultural system
High treatment uptake in human immunodeficiency virus/ hepatitis C virus-coinfected patients after unrestricted access to direct-acting antivirals in the Netherlands
Background
The Netherlands has provided unrestricted access to direct-acting antivirals (DAAs) since November 2015. We analyzed the nationwide hepatitis C virus (HCV) treatment uptake among patients coinfected with human immunodeficiency virus (HIV) and HCV.
Methods
Data were obtained from the ATHENA HIV observational cohort in which >98% of HIV-infected patients ever registered since 1998 are included. Patients were included if they ever had 1 positive HCV RNA result, did not have spontaneous clearance, and were known to still be in care. Treatment uptake and outcome were assessed. When patients were treated more than once, data were included from only the most recent treatment episode. Data were updated until February 2017. In addition, each treatment center was queried in April 2017 for a data update on DAA treatment and achieved sustained virological response.
Results
Of 23574 HIV-infected patients ever linked to care, 1471 HCV-coinfected patients (69% men who have sex with men, 15% persons who [formerly] injected drugs, and 15% with another HIV transmission route) fulfilled the inclusion criteria. Of these, 87% (1284 of 1471) had ever initiated HCV treatment between 2000 and 2017, 76% (1124 of 1471) had their HCV infection cured; DAA treatment results were pending in 6% (92 of 1471). Among men who have sex with men, 83% (844 of 1022) had their HCV infection cured, and DAA treatment results were pending in 6% (66 of 1022). Overall, 187 patients had never initiated treatment, DAAs had failed in 14, and a pegylated interferon-alfa–based regimen had failed in 54.
Conclusions
Fifteen months after unrestricted DAA availability the majority of HIV/HCV-coinfected patients in the Netherlands have their HCV infection cured (76%) or are awaiting DAA treatment results (6%). This rapid treatment scale-up may contribute to future HCV elimination among these patients